Skip to main content
Article
A Phase Ib/II Trial of Trastuzumab-DM1 (T-DM1) with Pertuzumab (P) for Women with HER2-positive, Locally Advanced or Metastatic Breast Cancer (BC) who were Previously Treated with Trastuzumab (T).
Journal of Clinical Oncology / American Society of Clinical Oncology (ASCO) Annual Meeting (2010)
  • Reshma Mahtani, Baptist Health South Florida
  • K. Miller
  • L. Gianni
  • F. Andre
  • V. Dieras
  • N. Harbeck
  • J. Huang
  • T. Shih
  • Y. Choi
  • H. Burris
Publication Date
2010
Citation Information
Reshma Mahtani, K. Miller, L. Gianni, F. Andre, et al.. "A Phase Ib/II Trial of Trastuzumab-DM1 (T-DM1) with Pertuzumab (P) for Women with HER2-positive, Locally Advanced or Metastatic Breast Cancer (BC) who were Previously Treated with Trastuzumab (T)." Journal of Clinical Oncology / American Society of Clinical Oncology (ASCO) Annual Meeting Vol. 28 Iss. 15S (2010)
Available at: http://works.bepress.com/reshma-mahtani/9/